SAB Biotherapeutics, Inc. Warrant
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SABSW and buy or sell other stocks, ETFs, and their options commission-free!About SABSW
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company, which engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases.
CEOSamuel J. Reich
CEOSamuel J. Reich
Employees—
Employees—
HeadquartersMiami Beach, Florida
HeadquartersMiami Beach, Florida
Founded2014
Founded2014
Employees—
Employees—
SABSW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume19.85K
Average volume19.85K
High today$0.0253
High today$0.0253
Low today$0.0232
Low today$0.0232
Open price$0.025
Open price$0.025
Volume11.17K
Volume11.17K
52 Week high$0.18
52 Week high$0.18
52 Week low$0.0205
52 Week low$0.0205
Stock Snapshot
The current SAB Biotherapeutics, Inc. Warrant(SABSW) stock price is $0.02.
On 2025-12-08, SAB Biotherapeutics, Inc. Warrant(SABSW) stock moved within a range of $0.02 to $0.03. With shares now at $0.02, the stock is trading +0.4% above its intraday low and -7.9% below the session's peak.
Trading activity shows a volume of 11.17K, compared to an average daily volume of 19.85K.
The stock's 52-week range extends from a low of $0.02 to a high of $0.18.
The stock's 52-week range extends from a low of $0.02 to a high of $0.18.